• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Novocure Ltd Ord Sh (NQ: NVCR )

    14.72 -0.78 (-5.00%)
    Streaming Delayed Price Updated: 1:16 PM EDT, Oct 3, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Novocure Ltd Ord Sh

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    16 17 Next >
    Novocure to Report Third Quarter 2024 Financial Results
    From Novocure
    Via Business Wire
    Novocure to Present Real-World Data at ESMO 2024 Demonstrating Improved Survival Outcomes for Newly Diagnosed Glioblastoma Patients with Increased Use of Tumor Treating Fields (TTFields) Therapy
    From Novocure
    Via Business Wire
    Why NovoCure Stock Dived by 13% This Week
    Investors found the announced changes to the company's C-suite unsettling. 
    Via The Motley Fool
    Novocure Announces Planned CEO Transition
    From Novocure
    Via Business Wire
    Beyond The Numbers: 4 Analysts Discuss NovoCure Stock
    Via Benzinga
    Breaking Down NovoCure: 4 Analysts Share Their Views
    Via Benzinga
    A Closer Look at 7 Analyst Recommendations For NovoCure
    Via Benzinga
    Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Novocure to Participate in 2024 Wells Fargo Healthcare Conference
    From Novocure
    Via Business Wire
    Unveiling 8 Analyst Insights On NovoCure
    Via Benzinga
    Novocure Highlights TTFields Therapy in Treatment of Non-Small Cell Lung Cancer at 2024 World Conference on Lung Cancer
    From Novocure
    Via Business Wire
    Chips, Glorious Chips!
    Someone's gotta make 'em, and someone's gotta buy 'em. 
    Via The Motley Fool
    PayPal Posts Upbeat Earnings, Joins Sprouts Farmers Market, Stanley Black & Decker, Phillips 66 And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    NovoCure (NVCR) Q2 2024 Earnings Call Transcript
    NVCR earnings call for the period ending June 30, 2024. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    NVCR Stock Earnings: NovoCure Beats EPS, Beats Revenue for Q2 2024
    NVCR stock results show that NovoCure beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    Novocure Reports Second Quarter 2024 Financial Results
    From Novocure
    Via Business Wire
    Novocure to Report Second Quarter 2024 Financial Results
    From Novocure
    Via Business Wire
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    METIS Phase 3 Clinical Trial Met Primary Endpoint Significantly Delaying Time to Intracranial Progression with Improved Quality of Life Deterioration-Free Survival
    From Novocure
    Via Business Wire
    Overseas Shipholding, Micron, Squarespace, Incyte And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    Double-Up Delights: 7 Stocks Poised to Soar 100% by 2025
    These stocks to buy are expected to double by 2025 and could turn mundane market returns into something bigger with a willingness to bet. 
    Via InvestorPlace
    NovoCure (NVCR) Q1 2024 Earnings Call Transcript
    NVCR earnings call for the period ending March 31, 2024. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    NVCR Stock Earnings: NovoCure Beats EPS, Beats Revenue for Q1 2024
    NVCR stock results show that NovoCure beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Novocure Secures New $400 Million Multi-Tranche Non-Dilutive Debt Financing from Pharmakon
    From Novocure
    Via Business Wire
    Novocure Reports First Quarter 2024 Financial Results
    From Novocure
    Via Business Wire
    Results of Novocure’s METIS Phase 3 Clinical Trial for Patients with Brain Metastasis from Non-Small Cell Lung Cancer to be Presented as Late-Breaking Abstract at ASCO 2024
    From Novocure
    Via Business Wire
    Novocure Announces 20 Presentations On Tumor Treating Fields, Highlighting Preclinical Effects in Pancreatic Cancer and Immune Effects, at American Association for Cancer Research (AACR) Annual Meeting 2024
    From Novocure
    Via Business Wire
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Novocure to Report First Quarter 2024 Financial Results
    From Novocure
    Via Business Wire
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    16 17 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.